Wilkins Score in Echocardiography
The Wilkins score is an echocardiographic scoring system (range 0-16) that evaluates four mitral valve characteristics—leaflet mobility, leaflet thickening, leaflet calcification, and subvalvular thickening—with each component graded 1-4 points, and it serves as the primary tool for determining patient suitability for percutaneous balloon mitral valvuloplasty (PBMV) in mitral stenosis.
Score Components and Grading
The Wilkins score assesses four anatomical features of the mitral valve apparatus:
- Leaflet mobility (1-4 points)
- Leaflet thickening (1-4 points)
- Leaflet calcification (1-4 points)
- Subvalvular apparatus thickening (1-4 points)
Each component receives 1 point (minimal involvement) to 4 points (severe involvement), yielding a total score of 4-16 points 1.
Clinical Application for PBMV Selection
Favorable Anatomy (Score ≤8)
Patients with Wilkins score ≤8 are ideal candidates for PBMV and should undergo the procedure when symptomatic with mitral valve area ≤1.5 cm² 1. This group demonstrates:
- 84% optimal outcomes (≥25% increase in valve area to >1.5 cm²)
- Low complication rates
- Excellent long-term event-free survival
Intermediate/Unfavorable Anatomy (Score 9-11)
For scores 9-11, PBMV remains reasonable in symptomatic patients (NYHA class III-IV) who are poor surgical candidates or refuse surgery, despite suboptimal valve anatomy 1. The evidence shows that 42% of patients with Wilkins score >8 still achieve optimal outcomes 1. However, these patients require:
- Experienced operators
- Careful patient selection considering clinical characteristics beyond the score
- Detailed discussion of higher complication risks
Very High Scores (Score ≥12)
Patients with scores ≥12 typically require surgical intervention rather than PBMV, as procedural success rates drop significantly 2.
Important Limitations and Caveats
Commissural Calcification Matters More Than Total Score
The presence of commissural calcification is an independent predictor of adverse outcomes that may be more important than the Wilkins score itself 3. Recent evidence demonstrates:
- Commissural calcification increases odds of significant mitral regurgitation 3.9-fold at mid-term follow-up (OR: 3.90,95% CI 2.61-5.83) 3
- 38% of patients with commissural calcium still achieve event-free survival at 1.8 years 1
- Combined assessment of Wilkins score AND commissural calcification provides superior risk stratification 3
Newer Scoring Systems Show Better Prediction
While the Wilkins score remains the guideline-recommended standard 2, 1, research demonstrates that:
- 3D echocardiographic scoring (ROC AUC 0.98) outperforms Wilkins score (ROC AUC 0.83) for predicting procedural success 4
- Integrated approaches combining Wilkins score with commissural area ratio and leaflet displacement improve risk classification (net reclassification improvement 45.2%) 5
- Quantitative parameters (commissural area ratio ≥1.25, leaflet displacement ≤12 mm) provide more objective assessment 5
Practical Algorithm for Decision-Making
- Calculate Wilkins score on transthoracic echocardiography
- Assess commissural calcification separately (presence, location, severity)
- Exclude left atrial thrombus with transesophageal echocardiography before PBMV 2
- Assess mitral regurgitation severity (≥moderate MR is contraindication)
Decision pathway:
- Score ≤8 + no commissural calcification + symptomatic: Proceed with PBMV 1
- Score ≤8 + commissural calcification present: PBMV reasonable but expect higher MR risk 3
- Score 9-11 + NYHA III-IV + high surgical risk: Consider PBMV with experienced operator 1
- Score ≥12 or bi-commissural calcification: Favor surgical intervention 2
Key Pitfalls to Avoid
Do not rely solely on Wilkins score when commissural calcification is present—this is a critical independent predictor that the traditional score underweights 3. The score was developed before recognition of commissural calcification's importance.
Do not deny PBMV to all patients with scores >8—42% still achieve optimal outcomes, particularly if they lack commissural calcification and have other favorable clinical characteristics 1.
Always perform TEE before PBMV to exclude left atrial thrombus, which may be missed on transthoracic imaging alone 2, 6.